Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.320
-0.160 (-3.57%)
At close: Aug 24, 2026, 4:00 PM EDT
4.347
+0.027 (0.63%)
After-hours: Aug 24, 2026, 5:19 PM EDT
Camp4 Therapeutics Revenue
Camp4 Therapeutics had revenue of $1.78M in the quarter ending June 30, 2026, with 18.84% growth. This brings the company's revenue in the last twelve months to $4.22M, up 40.21% year-over-year. In the year 2025, Camp4 Therapeutics had annual revenue of $3.50M with 436.50% growth.
Revenue (ttm)
$4.22M
Revenue Growth
+40.21%
P/S Ratio
64.45
Revenue / Employee
$87,833
Employees
48
Market Cap
271.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.50M | 2.85M | 436.50% |
| Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CAMP News
- 8 days ago - Camp4 Therapeutics reports Q2 EPS (58c), consensus (21c) - TheFly
- 8 days ago - Camp4 Therapeutics price target raised to $15 from $12 at Piper Sandler - TheFly
- 11 days ago - CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 11 days ago - Camp4 Therapeutics Quarterly report: Q2 2026 - Filings
- 11 days ago - Camp4 Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - CAMP4 advances rare disease treatment for SYNGAP1 into human trials - CNBC
- 18 days ago - Camp4 Therapeutics Registration statement: Registration filing - Filings
- 20 days ago - CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement - GlobeNewsWire